SCHEMBL3165629

SCHEMBL3165629

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccc(C)cc3)C(C)C2)nc(-c2ccccc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.40
▸ ADORA1 P30542 6/20 0.40
▸ MAPT P10636 5/20 0.40
▸ ADORA2A P29274 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GFER P55789 1/20 0.38
▸ ADORA3 P0DMS8 6/20 0.37
▸ ADORA2B P29275 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162603 0.93 GSK3B (0.48) GSK3BMAPTKDM4ELMNAALDH1A1
SCHEMBL3169880 0.92 ADORA3 (0.46) MAPTKDM4ELMNAALDH1A1HTT
SCHEMBL3162425 0.82 EGFR (0.53) MAPTKDM4ELMNAALDH1A1HTT
SCHEMBL3171920 0.82 ADORA1 (0.47) GSK3BADORA1ADORA2AKDM4EALDH1A1
SCHEMBL3170234 0.82 ADORA1 (0.42) ADORA1ADORA2AALDH1A1ADORA3ADORA2B
SCHEMBL3170239 0.82 ADORA1 (0.42) ADORA1ADORA2AALDH1A1ADORA3ADORA2B
SCHEMBL3258722 0.81 EGFR (0.46) GSK3BADORA1MAPTADORA2AKDM4E
SCHEMBL3163144 0.81 ADORA3 (0.46) ADORA1MAPTADORA2AKDM4ELMNA
SCHEMBL3163125 0.81 NPC1 (0.47) GSK3BADORA1MAPTADORA2AKDM4E
SCHEMBL3164709 0.81 NPC1 (0.47) GSK3BADORA1MAPTADORA2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback